Skip to main content

ORIGINAL RESEARCH article

Front. Aging Neurosci., 04 July 2023
Sec. Parkinson’s Disease and Aging-related Movement Disorders
This article is part of the Research Topic Insights in Parkinson’s Disease and Aging-related Movement Disorders: 2022 View all 12 articles

Lycium barbarum glycopetide prolong lifespan and alleviate Parkinson’s disease in Caenorhabditis elegans

\r\nJingming Zheng&#x;Jingming Zheng1†Zhenhuan Luo&#x;Zhenhuan Luo1†Kin Chiu&#x;Kin Chiu2†Yimin LiYimin Li1Jing YangJing Yang3Qinghua ZhouQinghua Zhou3Kwok-Fai So*Kwok-Fai So4*Qin-Li Wan*Qin-Li Wan1*
  • 1Department of Pathogen Biology, School of Medicine, Jinan University, Guangzhou, Guangdong, China
  • 2State Key Lab of Brain and Cognitive Sciences, Department of Psychology, The University of Hong Kong, Hong Kong, Hong Kong SAR, China
  • 3Faculty of Medical Science, The Biomedical Translational Research Institute, Jinan University, Guangzhou, Guangdong, China
  • 4Guangdong-Hongkong-Macau Institute of Central Nervous System (CNS) Regeneration, Ministry of Education Central Nervous System (CNS) Regeneration Collaborative Joint Laboratory, Jinan University, Guangzhou, Guangdong, China

Introduction: Lycium barbarum glycopeptide (LbGp) is the main bioactive compound extracted from the traditional Chinese medicine. L. barbarum berries and has been proven to have numerous health benefits, including antioxidative, anti-inflammatory, anticancer, and cytoprotective activities. However, the antiaging effect of LbGp remains unknown.

Methods: The lifespan and body movement of C. elegans were used to evaluate the effect of LbGp on lifespan and health span. The thrashing assay was used to determine the role of LbGp in Parkinson’s disease. To investigate the mechanisms of LbGp-induced antiaging effects, we analyzed changes in lifespan, movement, and the expression of longevity-related genes in a series of worm mutants after LbGp treatment.

Results: We found that LbGp treatment prolonged the lifespan and health span of C. elegans. Mechanistically, we found that LbGp could activate the transcription factors DAF-16/FOXO, SKN-1/Nrf2, and HSF-1, as well as the nuclear receptor DAF-12, thereby upregulating longevity-related genes to achieve lifespan extension. In addition, we found that the lifespan extension induced by LbGp partially depends on mitochondrial function. Intriguingly, LbGp also ameliorated neurodegenerative diseases such as Parkinson’s disease in a DAF-16-, SKN-1-, and HSF-1-dependent manner.

Conclusion: Our work suggests that LbGp might be a viable candidate for the treatment and prevention of aging and age-related diseases.

1. Introduction

Aging, an intrinsic biological process of life, is commonly characterized as a progressive loss of physiological integrity, eventually leading to organ failure (Moskalev et al., 2022). This deterioration of aging is the principal risk factor for many chronic diseases, such as cancer, neurodegenerative disorders, diabetes and cardiovascular diseases (Niccoli and Partridge, 2012). Currently, the percentage of the population over the age of 65 years old has been increasing steadily, which has led to a global burden of age-related chronic diseases (Stegemann et al., 2010). Therefore, slowing the rate of biological aging and the progression of aging-associated diseases will considerably improve the quality of human life. For years, people have been searching for and discovering many natural substances that can prevent aging and aging-related diseases. For example, previous studies have shown that numerous plant extracts and natural bioactive products, such as usnic acid (Xiao et al., 2022), urolithin (Ryu et al., 2016), resveratrol (Park et al., 2012), saponins isolated from Radix polygalae (Zeng et al., 2021), and flavonoids from Lycium barbarum (L. barbarum) leaves (Niu et al., 2022), have lifespan-extending properties in different organism models.

Plant polysaccharides play increasingly important roles in human health and nutrition due to their multiple physiological activities and pharmacological functions (Wang et al., 2020). The berries of L. barbarum (Goji) (a Solanaceous defoliated shrubbery), a well-known traditional Chinese medicine and super functional food, contain a variety of health-promoting bioactive compounds with numerous nutritional and pharmacological functions (Jin et al., 2013). L. barbarum polysaccharides (LBPs) are the main functional constituents of L. barbarum and are composed of a variety of acidic heteropolysaccharides and polypeptides or proteins (Masci et al., 2018). Numerous studies have shown different biological activities of LBPs, including antioxidation (Liang et al., 2021), anticancer effects (Mao et al., 2011), antiaging effects (Tang et al., 2019; Zhang et al., 2019), immunoregulation (Ding et al., 2019), reproductive protection, and cytoprotective activity (Zhang et al., 2020). Among them, increasing attention has been given to the functions of LBPs in antioxidative stress and antiaging. Recently, researchers have deeply excavated the main antiaging active ingredients in LBPs and elucidated the underlying molecular mechanisms. For example, Huang W. et al. (2022) showed that the arabinogalactan-protein complex LBGP70 from crude LBPs were able to delay cellular senescence by activating aging-related genes. Zhang et al. (2022) revealed that the acidic heteropolysaccharide LFP-05S from LBPs could prolong the lifespan and enhance stress resistance in Caenorhabditis elegans (C. elegans) by eliminating unfavorable ROS overproduction.

Recently, researchers further separated and purified LBPs and obtained another component, L. barbarum glycopeptide (LbGp), which is the most promising monomeric substance (Peng et al., 2001). LbGp is a kind of glycoprotein whose monosaccharide composition includes glucose, arabinose and galactose and contains 30% protein linked to glycans by O-linkages (Tian, 1995). Accumulating evidence has shown that LbGp protects the kidney, promotes reproduction, enhances immunity, and exerts antitumor and anti-inflammatory effects (Gong et al., 2020; Zhou et al., 2022). The pharmacological functions of LbGp have many similarities with LBPs but also have many differences. For example, previous studies have shown that both LBPs and LbGp can maintain the balance of the intestinal environment by promoting the growth of probiotics, but their effects on the abundance of different types of gut microflora, such as Akkermansia and Alistipes, are distinctly different (Huang Y. et al., 2022). Therefore, it is valuable to deeply explore the pharmacological activities and underlying molecular mechanisms of LbGp. Considering that LBPs have antioxidant, antiaging and neuroprotective effects, and LbGp is the main active ingredient in LBP, we questioned whether and how LbGp plays a role in ameliorating aging and aging-related disease. Therefore, in this study, we used C. elegans to explore the longevity effect of LbGp and its underlying molecular mechanisms.

The nematode C. elegans is a robust multicellular model organism with multiple advantages, including a short life cycle, simple physiological structure and easy procedures for manipulation (Wan et al., 2021). Most aging-associated signaling pathways are evolutionarily conserved between C. elegans and mammals, including the insulin/insulin-like growth factor signaling (IIS) pathway, dietary restriction (DR)-related pathway, reproductive signaling pathway and mitochondrial dysfunction-related pathways (Xiao et al., 2022). Therefore, C. elegans has been widely used in aging research and screening of natural bioactive extracts with antiaging effects (Park et al., 2012; Ryu et al., 2016; Zeng et al., 2021; Xiao et al., 2022).

Our results showed that LbGp significantly increased the lifespan and health span and ameliorated PD-related features in C. elegans. Further studies revealed that several aging-related signaling pathways, including the IIS pathway, reproductive signaling pathway and mitochondrial function, were involved in the LbGp-induced longevity effect.

2. Materials and methods

2.1. Reagents, C. elegans strains, and maintenance

Lycium barbarum glycopeptide (LbGp) was provided by Ningxia Tianren Goji Biotechnology. LbGp was dissolved in water, and all NGM plates with LbGp were equilibrated overnight before use.

The Caenorhabditis Genetics Center (University of Minnesota, Minneapolis, MN, USA) provided the C. elegans strains used in this study: wild-type Bristol N2, GR1310 akt-1(mg144)V, CB1370 daf-2(e1370)III, CF1038 daf-16(mu86)I, PS3551 hsf-1(sy441)I, CF1903 glp-1(e2144)III, AA86 daf-12(rh61rh411)X, CB4876 clk-1(e2519)III, MQ887 isp-1(qm150)IV, RB754 aak-2(ok524)X, CF1553 muIs84 [(pAD76)sod-3p::GFP + rol-6(su1006)], CL2070 dvIs70 [hsp-16.2p::GFP + rol-6(su1006)], and UM0010 dat-1p::GFP; aex-3p::α-syn(A53T). New strains were generated by standard genetic crosses, and genotypes were confirmed by PCR or sequencing. Here, UM0010 was crossed with CF1038, PS3551, and AA86 to create the double mutants daf-16(mu86)I; dat-1p::GFP; aex-3p::α-syn(A53T), hsf-1(sy441)I; dat-1p::GFP; aex-3p::α-syn(A53T), and daf-12(rh61rh411)X; dat-1p::GFP; aex-3p::α-syn(A53T). All strains were grown and maintained using standard protocols (Jia et al., 2022).

2.2. Lifespan assays

All lifespan experiments, except for those with the CF1903 strains, were performed according to the standard protocols at 20°C, as previously described (Jia et al., 2022). In brief, approximately 100–150 young adult worms were picked into fresh plates containing different concentrations of LbGp and 10 μM 5-fluoro-2′-deoxyuridine (FUDR, Sigma), which was used to prevent progeny production. For CF1903, the synchronized L1 worms were grown at 20°C for 12 h, transferred to 25°C until the young adult stage to eliminate the germline, and finally returned to 20°C for the lifespan assays. For all lifespan assays, heat-inactivated (65°C, 30 min) Escherichia coli OP50 was used as food to prevent the metabolism of LbGp by bacteria. Worms were transferred to fresh plates with LbGp every other day. Death events were scored daily, and the lifespan assays were repeated three times. Statistical analyses were performed using the SPSS package, and the P-value was determined by the log-rank (Mantel-Cox) method. P-value < 0.05 was considered statistically significant. The mean, SEM, P-value and lifespan value are summarized in Supplementary Table 1.

2.3. Movement assays

The body movement assays were performed using the standard protocol as previously described (Jia et al., 2022). In brief, approximately 150 young adult worms were transferred to plates with or without LbGp at 20°C and maintained as described in the lifespan assays. Then, the movement of the worms was scored daily. When the plates were tapped, the worms moving in a continuous and coordinated sinusoidal pattern were defined to have fast movement; otherwise, they were defined as having non-fast movement.

2.4. Thrashing assays

The synchronized L1 PD model worms were grown at 20°C on NGM plates to the young adult stage, transferred to FUDR-containing plates with or without LbGp at 25°C and maintained as described in the lifespan assays. Day 5 worms were picked into a drop of M9 buffer, and the thrashing was recorded for 30 s at × 0.75 magnification with a Motic stereomicroscope as previously described (Huang et al., 2021). At least 30 worms were counted per experiment, and the thrashing assays were repeated three times.

2.5. RNA extraction and quantitative RT-PCR

The synchronized L1 worms were grown on plates with or without LbGp to the young adult stage, collected in M9 buffer and washed several times. Worm samples were resuspended using AG RNAex PRO reagent (Accurate Biology, Changsha, China), and total RNA was isolated by chloroform extraction and isopropanol precipitation. Then, 500 ng RNA was used to synthesize cDNA with a high-capacity cDNA transcription kit (RK20400, ABclonal, Wuhan, China). Quantitative RT-PCR was performed using SYBR Green Select Master Mix (RK21203, ABclonal, Wuhan, China) on a LightCycler480 real-time system (Roche, USA), and each assay was repeated three times. The mRNA expression of the genes was quantified after normalization to the reference gene cdc-42, and the P-value was computed using the two-tailed Student’s t-test. The primers used in this study are shown in Supplementary Table 2.

2.6. Fluorescence microscopy and image analyses

For analysis of the fluorescence intensity of sod-3p::GFP and hsp-16.2p::GFP, the CF1553 and CL2070 strains were grown on plates with or without LbGp to the young adult stage. For CF1553, animals were picked onto 2% agar pads after anesthetizing with 10 μM levamisole, and then, the fluorescence was observed under a Nikon Ti2-U microscope with a 20 × air objective. For CL2070, young adult worms were heated at 35°C for 2 h to stimulate the expression of hsp-16.2p::GFP. After recovery at 20°C for 12 h, the CL2070 worms were observed using a Nikon Ti2-U fluorescence microscope with a 20 × air objective. The fluorescence intensity was quantified using ImageJ software. At least 30 animals were used in each group. The P-value was calculated by the two-tailed Student’s t-test.

2.7. Measurement of reactive oxygen species (ROS)

2′7′-Dichlorofluorescein diacetate (H2DCF-DA) was used to detect the levels of intracellular ROS. The synchronized L1 worms were grown on plates with or without LbGp to the young adult stage, transferred to plates with 10 μM H2DCF-DA and incubated for 1 h. In addition, to create oxidative stress conditions, worms were treated with 5 mM paraquat for 12 h before staining with H2DCF-DA. Then, animals were picked onto 2% agar pads after anesthetizing with 10 μM levamisole, and the fluorescence was observed under a Nikon Ti2-U microscope with a 20 × air objective. The fluorescence intensity was quantified using ImageJ software. At least 30 animals were used in each group. The P-value was calculated by the two-tailed Student’s t-test.

2.8. Western blot analyses

CF1553 and CL2070 worms were treated and maintained as described in the section on quantification of fluorescence intensity. Worms were collected in M9 buffer, subjected to three rounds of freezing and thawing, and then lysed in RIPA buffer. The protein samples were boiled at 95°C for 5 min after quantification using a BCA Protein Assay Kit. Next, the protein samples were separated by SDS-PAGE and transferred to PVDF membranes. The membranes were then blocked in 5% milk and incubated with primary antibodies against β-actin (1:5,000, Sigma-Aldrich, A1978) or GFP (1:5,000, Roche, 11814460001). The primary antibodies were visualized by horseradish peroxidase-conjugated anti-mouse secondary antibody and ECL Western Blotting Substrate.

2.9. Statistical analyses

The lifespan statistical analyses were performed using the SPSS package, and survival analyses were conducted using the Kaplan-Meier method. P-value was determined by log-rank (Mantel-Cox) test for individual experiments. Other data were analyzed by the two-tailed Student’s t-test. Statistical significance was defined as P < 0.05 and represented as stars (*P < 0.05, **P < 0.01, and ***P < 0.001). All experiments were repeated three times independently.

3. Results

3.1. LbGp enhances lifespan and ameliorates PD-related features in C. elegans

To determine whether LbGp plays a role in lifespan regulation, we treated adult worms with different doses of LbGp (200, 400, 600, and 800 μg/mL) and recorded their survival. We found that LbGp dose-dependently enhanced the lifespan of wild-type N2 worms (Figures 1A, B), with 600 μg/mL LbGp showing the best lifespan extension effect (Figures 1A, B). Therefore, 600 μg/mL was selected as the optimal concentration in all subsequent experiments. We also investigated the effect of LbGp on the health span by examining the effect of LbGp on body movement, an aging-related parameter (Huang et al., 2004). The results showed that the period of fast movement was significantly prolonged when worms were treated with LbGp compared with that of the untreated controls (Figure 1C). Taken together, these results demonstrated that LbGp not only prolonged lifespan but also had pronounced health span effects in C. elegans, with a concentration of 600 μg/mL showing the best effect.

FIGURE 1
www.frontiersin.org

Figure 1. LbGp extended the lifespan and health span of C. elegans and improved the body motility of the nematode model of PD. (A) Lifespan analyses of N2 worms cultured at different doses of LbGp (200, 400, 600, and 800 μg/mL). (B) Statistical analyses of the effect of LbGp on N2 worms lifespan. The data are presented as the mean ± SD of three independent lifespan assays. (C) Movement analyses of N2 worms treated with LbGp (600 μg/mL) or vehicle (water). (D) Body bend analyses of the PD model strain UM0010 [aex-3p::α-syn(A53T)] treated with LbGp (600 μg/mL) or vehicle (water) at Day 5. In panels (A,B), lifespan analyses were performed using Kaplan-Meier plotter, and the P-value was calculated by the log-rank test. In panels (C,D), mean ± SD, n ≥ 30 per group. **P < 0.01, ***P < 0.001 (two-tailed Student’s t-test).

Given that LbGp can extend lifespan and health span, we asked whether it could have benefits on aging-related diseases, such as Parkinson’s disease (PD). UM0010 is a well-characterized PD model in C. elegans by pan-neuron overexpression of human α-synuclein (A53T), which recapitulates some distinct characteristics of PD, including the loss of dopaminergic neurons and motor deficits (Deng and Yuan, 2014). Using UM0010 transgenic worms, we found that LbGp significantly increased the rate of body bending of UM0010 worms at Day 5 (Figure 1D) through a thrashing assay, suggesting that LbGp could ameliorate PD features in C. elegans.

3.2. LbGp-induced lifespan extension requires the IIS pathway

We next determined which molecular mechanisms contribute to the lifespan extension conferred by LbGp. The transcription factor DAF-16, a homolog of human Forkhead box O (FOXO), is one of the main downstream regulators of oxidative stress resistance and the aging process (Li et al., 2019). DAF-16 is the determinant of the longevity effect induced by LBPs and L. barbarum berry extracts (Zhang et al., 2019; Xiong et al., 2021). Therefore, we first investigated the role of DAF-16 in the beneficial longevity induced by LbGp. Our results showed that the lifespan of daf-16(mu86) worms was not extended by LbGp (Figure 2A). In addition, we found that the transcription levels of the DAF-16 target genes (ctl-1, ctl-2, sod-2, and sod-3) were significantly increased by LbGp (Figure 2B). Furthermore, using the GFP fused reporter strain CF1553 (containing a sod-3p::GFP fusing transgene), we found that both the fluorescence intensity (Figures 2C, D) and GFP expression level (Figure 2E) were considerably increased when worms treated with LbGP, suggesting that LbGp triggered the expression of sod-3, a specific downstream target gene of DAF-16. Consequently, these results indicated that LbGp-induced lifespan extension depends on DAF-16. In addition, we found that LbGp was unable to increase the rate of body bending of UM0010 worms with a daf-16-null background (Figure 2F), indicating that similar to lifespan extension, amelioration of PD conferred by LbGp also depends on DAF-16.

FIGURE 2
www.frontiersin.org

Figure 2. LbGp-induced lifespan extension depended on the IIS pathway. (A) Survival curves of daf-16(mu86) mutants treated with LbGp (600 μg/mL) or vehicle (water). (B) The relative mRNA expression of DAF-16-targeted genes (ctl-1, ctl-2, ctl-3, sod-1, sod-2, and sod-3) in N2 worms treated with LbGp (600 μg/mL) or vehicle (water). (C,D) Image (C) and quantification (D) of GFP fluorescence in the head region of the sod-3-reporter strain CF1553 (sod-3p::GFP) treated with LbGp (600 μg/mL) or vehicle (water). (E) Western blot analyses of GFP from LbGp-treated and non-LbGp-treated CF1553 (sod-3p::GFP) transgenic worms. The experiment was repeated three times. The corresponding uncropped western blot figure is shown in Supplementary Figure 1A. (F) Body bend analyses of the strain daf-16(mu86); aex-3p::α-syn(A53T) treated with LbGp (600 μg/mL) or vehicle (water) at Day 5. (G,H) Survival curves of akt-1(mg144) (G) and daf-2(e1370) (H) mutants treated with LbGp (600 μg/mL) or vehicle (water). In panels (D,F), mean ± SD, n ≥ 30 per group. In panels (B,D,F), ns, not significant, *P < 0.05, **P < 0.01, and ***P < 0.001 (two-tailed Student’s t-test).

Considering that DAF-16 is a key effector downstream of the IIS pathway, we speculated that the LbGp-induced longevity effects might depend on inhibiting the IIS signaling pathway, which is a well-known aging-related signaling pathway (Li et al., 2019). In C. elegans, DAF-2 is the insulin/IGF-1 transmembrane receptor homologous to mammals, which cascades to regulate the activity of the phosphoinositide 3-kinase (PI3K)/Akt kinase, eventually leading to the nuclear translocation of DAF-16/FOXO transcription factor and regulating longevity (Li et al., 2019). Using daf-2(e1370) and akt-1(mg144) mutants, we found that LbGp-induced lifespan extension was abrogated by daf-2 and akt-1 mutants (Figures 2G, H), indicating that LbGp-induced lifespan extension was associated with the IIS signaling pathway.

3.3. The transcription factors SKN-1/Nrf2 and HSF-1 mediate LbGp-induced longevity

In addition to DAF-16, the transcription factor SKN-1 is a key longevity regulator downstream of the IIS signaling pathway, which activates various downstream antioxidant and phase II detoxification genes in response to oxidative stress (Tullet et al., 2008). Previous studies have shown that L. barbarum extracts and LBPs could activate the antioxidant system of C. elegans through the transcription factor SKN-1 to enhance oxidative stress resistance (Meng et al., 2022). We first analyzed the antioxidant activity of LbGp in worms by detecting intracellular ROS accumulation levels using H2DCF-DA (a free radical sensor that can be deacetylated by intracellular esterases to emit fluorescence signals associated with ROS). We found that LbGp treatment significantly reduced the level of ROS under normal conditions (Figure 3A) or oxidative stress conditions (treatment with paraquat) (Figure 3B), suggesting that LbGp has antioxidant capacity to scavenge harmful ROS. Then, we wondered whether SKN-1 functions in lifespan extension induced by LbGp. Conducting survival analyses, we found that similar to the results of daf-16, the LbGp-induced survival benefit was blocked by RNAi knockdown of skn-1 (Figures 3C, D). Moreover, we found that LbGp failed to improve motility in UM0010 worms under skn-1 RNAi conditions (Figure 3E). Altogether, these results demonstrated that amelioration of aging and aging-related PD conferred by LbGp required the transcription factor SKN-1.

FIGURE 3
www.frontiersin.org

Figure 3. LbGp-induced lifespan extension was mediated by the transcription factors HSF-1 and SKN-1/Nrf2. (A,B) Quantitation of intracellular levels of ROS in N2 worms treated with LbGp (600 μg/mL) or vehicle (water) under normal conditions (A) or oxidative stress conditions (treatment with 5 mM paraquat) (B). (C) Survival curves of N2 worms treated with LbGp (600 μg/mL) or vehicle (water) under skn-1 RNAi conditions. (D) Relative skn-1 mRNA expression in N2 worms fed HT115 bacteria carrying the skn-1 RNAi vector or empty vector L4440. (E) Body bend analyses of the PD model strain UM0010 [aex-3p::α-syn(A53T)] treated with LbGp (600 μg/mL) or vehicle (water) at Day 5 under skn-1 RNAi conditions. (F) Survival curves of hsf-1(sy441) mutants treated with LbGp (600 μg/mL) or vehicle (water). (G) Survival curves of N2 worms treated with LbGp (600 μg/mL) or vehicle (water) under hsf-1 RNAi conditions. (H) The relative mRNA expression of hsf-1-targeted genes (hsp-12.6, hsp-16.1, hsp-16.2, and hsp-70) in the N2 worms treated with LbGp (600 μg/mL) or vehicle (water). (I,J) Image (I) and quantification (J) of GFP fluorescence in the hsp-16.2-reporter strain CL2070 (hsp-16.2p::GFP) treated with LbGp (600 μg/mL) or vehicle (water). (K) Western blot analyses of GFP from LbGp-treated and non-LbGp-treated CL2070 (hsp-16.2p::GFP) transgenic worms. The experiment was repeated three times. The corresponding uncropped western blot figure is shown in Supplementary Figure 1B. (L) Body bend analyses of the strain hsf-1(sy441); aex-3p::α-syn(A53T) treated with LbGp (600 μg/mL) or vehicle (water) at Day 5. In panels (A,B,E,J,L), mean ± SD, n > 30 per group. In panels (A,B,D,E,H,J,L), ns, not significant, *P < 0.05, **P < 0.01, and ***P < 0.001 (two-tailed Student’s t-test).

The heat-shock transcription factor HSF-1, another downstream target of the IIS pathway, plays a key role in the lifespan-extending effects of LBPs (Chiang et al., 2012). We also determined the effect of LbGp on the hsf-1 mutant and found that LbGp-induced lifespan extension was abrogated in the hsf-1-null mutant (Figure 3F). Meanwhile, LbGp failed to prolong the lifespan in WT worms under hsf-1 RNAi conditions (Figure 3G). Subsequently, we also confirmed that the mRNA levels of HSF-1 targets, including hsp-12.6, hsp-16.1, hsp-16.2, and hsp-70, were obviously increased by LbGp (Figure 3H). Moreover, we observed an elevated transcription level of hsp-16.2 by detecting the fluorescence intensity and GFP protein level of the hsp-16.2p::GFP transgenic strains in the presence or absence of LbGp (Figures 3I, J, K). Similar to DAF-16 and SKN-1, we also found that the deletion of hsf-1 eliminated the beneficial effect of LbGp on PD models (Figure 3L). Collectively, these results demonstrated that the LbGp-induced longevity effect was attributed to regulation of the IIS signaling pathway in a DAF-16-, HSF-1- and SKN-1-dependent manner.

3.4. LbGp-induced longevity depends on the reproductive signaling pathway

In C. elegans, germline depletion extends lifespan by remodeling the transcriptional landscape through activation of several aging-related transcription factors, including DAF-16 and SKN-1 (Berman and Kenyon, 2006). Based on our results above, we questioned whether the LbGp-induced longevity effect was related to the reproductive signaling pathway. Our results showed that LbGp was unable to further increase the lifespan of glp-1(e2144) worms, a germline-less and long-lived mutant (Figure 4A). The nuclear steroid receptor DAF-12 is activated by bile acid-like steroids to extend lifespan in germline-less worms (Motola et al., 2006). A recent study showed that DAF-12 contributed to the lifespan extension conferred by LBPs in C. elegans (Zhang et al., 2019). Concordantly, we also found that LbGp failed to extend the lifespan of daf-12(rh61rh411) (Figure 4B). Additionally, LbGp significantly enhanced the expression of DAF-12 target genes (cdr-6 and lips-17) (Figure 4C). Furthermore, we found that improvement of motility of UM0010 worms was disappeared in a daf-12-null background (Figure 4D). Altogether, these findings illustrated that the survival benefits induced by LbGp were mediated by the reproductive signaling pathway.

FIGURE 4
www.frontiersin.org

Figure 4. LbGp-induced lifespan extension depended on the reproductive signaling pathway. (A,B) Survival curves of glp-1(e2144) (A) and daf-12(rh61rh411) (B) mutants treated with LbGp (600 μg/mL) or vehicle (water). (C) The relative mRNA expression of the daf-12-targeted genes (fard-1, cdr-6 and lips-17) in the N2 worms treated with LbGp (600 μg/mL) or vehicle (water). (D) Body bend analyses of the strain daf-12(rh61rh411); aex-3p::α-syn(A53T) treated with LbGp (600 μg/mL) or vehicle (water) at Day 5. In panel (D), mean ± SD, n > 30 per group. In panels (C,D), mean ± SD, ns, not significant, *P < 0.05 (two-tailed Student’s t-test).

3.5. LbGp-induced longevity partially depends on mitochondrial function

Attenuated mitochondrial respiratory function and mitochondrial dysfunction are major causes of aging. SKN-1 has been shown to improve mitochondrial function by regulating mitochondrial biogenesis, ultimately extending the lifespan of C. elegans (Palikaras et al., 2015). Thus, we further investigated the effect of LbGp on the long-lived mitochondrial mutants clk-1(e2519) and isp-1(qm150). clk-1 encodes the human coenzyme Q7 hydroxylase homolog, and isp-1 is the Rieske iron-sulfur polypeptide 1 homolog in C. elegans. Our results showed that the lifespan of clk-1(e2519) was unable to be extended by LbGp (Figure 5A), but that of isp-1(qm150) could be (Figure 5B), suggesting that the LbGp-induced longevity effect required mitochondrial function in a clk-1-specific manner.

FIGURE 5
www.frontiersin.org

Figure 5. LbGp-induced lifespan extension partially depended on mitochondrial function. (A–C) Survival curves of clk-1(e2519) (A), isp-1(qm150) (B) and aak-2(ok524) (C) mutants treated with LbGp (600 μg/mL) or vehicle (water). (D) Mechanisms of action of LbGp in C. elegans.

Mitochondrial are the central organelle of energy production. The discovery of a mechanism by which LbGp regulates lifespan associated with mitochondrial function motivated us to deduce whether LbGp prolongs lifespan by influencing energy generation. In C. elegans, aak-2 encodes a catalytic subunit of AMP-activated kinase (AMPK), which senses energy levels and is activated by a low ATP level to regulate lifespan (Apfeld et al., 2004). We found that LbGp could further extend the lifespan of the aak-2 mutant (Figure 5C), suggesting that aak-2 is dispensable for the survival advantage induced by LbGp. Therefore, this result indicated that LbGp-induced lifespan extension was independent of the regulation of energy production.

4. Discussion

Aging is always accompanied by a deterioration of physiological function and an increase in degenerative disease (e.g., Alzheimer’s disease and Parkinson’s disease) (Niccoli and Partridge, 2012). As the global population ages, the need to find substances that can treat aging-related diseases, delay the aging process, and prolong lifespan is urgent. Functional and nutraceutical foods have gradually attracted attention because of their few side effects. L. barbarum has been recognized and used as traditional Chinese medicine for 2,500 years, and its use is now expanding to all Western countries, where it is consumed mostly as food supplements (Amagase and Farnsworth, 2011). In this study, we found that LbGp, a potential ingredient of L. barbarum berry, could extend lifespan and health span, as well as alleviate the progression of aging-related PD. In an in-depth study of the mechanism, we found that the amelioration of aging and aging-related disease conferred by LbGp was mediated by regulating the IIS signaling pathway and reproductive signaling pathway, subsequently activating the stress response transcription factors DAF-16, HSF-1 and SKN-1 and the nuclear receptor DAF-12, thereby triggering the expression of downstream longevity-related target genes to extend lifespan. Furthermore, mitochondrial function was involved in the survival benefits induced by LbGp (Figure 5D).

The imbalance between the production and elimination of free radicals is one of the major factors in aging and aging-associated disorders, and the supplementation of antioxidants can delay aging and improve oxidative stress resistance (Hekimi et al., 2011). Previous studies have shown that LBPs have antioxidant bioactivity and can reduce DNA damage by eliminating free radicals and inhibiting oxidative stress (Zhang et al., 2017). Consistently, we also found that LbGp could activate the expression of several antioxidant genes. Moreover, we confirmed that SKN-1, a major oxidative stress response factor, contributes to LbGp-induced lifespan extension. These results demonstrated that, similar to LBPs, LbGp prolonged lifespan depending on its antioxidant bioactivity, at least in part. Indeed, we also found that LbGp extended lifespan in an antioxidant-independent manner, that is, regulation of glp-1 by LbGp. The longevity of germline-deficient mutants is associated with increased ROS in the soma (Wei and Kenyon, 2016). However, we found that LbGp, an antioxidant, did not influence the lifespan of glp-1(e2144) worms, which seems to contradict our observation that LbGp improves the antioxidant capacity. These findings implied that LbGp-induced lifespan extension in C. elegans depended not only on the antioxidant capacity but also on other biological activities.

Aging is the greatest risk factor for most age-related disorders, and delaying the rate of biological aging through the consumption of antiaging drugs or foods is able to slow the onset and progression of age-related diseases (Xiao et al., 2022). In the present study, we found that LbGp could improve motility in a PD model of C. elegans through mechanisms consistent with antiaging, indicating that LbGp can ameliorate the progression of PD. In support of our findings, previous studies reported that the crude extracts and polysaccharides of L. barbarum berry have protective effects against many aging-associated disorders, including cardiovascular diseases and neurodegenerative diseases. For example, supplementation with LBPs protected neurons against β-amyloid-induced apoptosis and improved the learning and memory abilities of Sprague Dawley rats with scopolamine-induced brain injury; crude extracts from LB can alleviate the neurotoxicity of α-synuclein protein, β-amyloid, and Aβ peptide in vitro and in vivo (Meng et al., 2022). Those studies and our present results indicated that LbPs could improve the symptoms of neurodegenerative disorders and that LbGp may be the one of the main active ingredients in LBPs exert these protective effects.

5. Conclusion

In conclusion, the innovation of this study lies in the discovery that LbGp extracted from L. barbarum berries can prolong the lifespan and health span and delay the occurrence of aging-related diseases such as PD in C. elegans. These findings provide a new strategy for preventing aging and aging-related diseases. Mechanistically, the molecular mechanism of LbGp-induced longevity is closely related to the IIS pathway, reproductive signaling pathway and mitochondrial function-related signaling pathway. It is necessary to expand our findings on LbGp to mammalian model organisms. Therefore, in future research, we will continue to search for new protective effects against other neurodegenerative diseases and clarify the molecular mechanisms of LbGp against aging and aging-related diseases in different animal models.

Data availability statement

All data needed to evaluate the conclusions in this manuscript are present in this manuscript and/or the Supplementary material. Requests to access the datasets should be directed to Q-LW, wanqinli@hotmail.com.

Author contributions

JZ: investigation, methodology, software, visualization, and writing–editing. ZL: investigation, methodology, visualization, and writing–original draft. KC: investigation, methodology, and visualization. YL and JY: methodology. QZ: investigation and funding acquisition. K-FS: investigation and writing–reviewing and editing. Q-LW: investigation, writing–reviewing and editing, and funding acquisition. All authors contributed to the article and approved the submitted version.

Funding

This work was supported by the National Key R&D Program of China (2021YFA0804903), the National Natural Science Foundation of China (No. 82001465), and the Guangdong Provincial Basic Research Program, China (2020A1515111026).

Acknowledgments

We thank the Caenorhabditis Genetic Center (CGC) for providing the worm strains.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnagi.2023.1156265/full#supplementary-material

References

Amagase, H., and Farnsworth, N. R. (2011). A review of botanical characteristics, phytochemistry, clinical relevance in efficacy and safety of Lycium barbarum fruit (Goji). Food Res. Int. 44, 1702–1717. doi: 10.1016/j.foodres.2011.03.027

CrossRef Full Text | Google Scholar

Apfeld, J., O’connor, G., Mcdonagh, T., Distefano, P. S., and Curtis, R. (2004). The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev. 18, 3004–3009. doi: 10.1101/gad.1255404

PubMed Abstract | CrossRef Full Text | Google Scholar

Berman, J. R., and Kenyon, C. (2006). Germ-cell loss extends C. elegans life span through regulation of DAF-16 by kri-1 and lipophilic-hormone signaling. Cell 124, 1055–1068. doi: 10.1016/j.cell.2006.01.039

PubMed Abstract | CrossRef Full Text | Google Scholar

Chiang, W. C., Ching, T. T., Lee, H. C., Mousigian, C., and Hsu, A. L. (2012). HSF-1 regulators DDL-1/2 link insulin-like signaling to heat-shock responses and modulation of longevity. Cell 148, 322–334. doi: 10.1016/j.cell.2011.12.019

PubMed Abstract | CrossRef Full Text | Google Scholar

Deng, H., and Yuan, L. (2014). Genetic variants and animal models in SNCA and Parkinson disease. Ageing Res. Rev. 15, 161–176. doi: 10.1016/j.arr.2014.04.002

PubMed Abstract | CrossRef Full Text | Google Scholar

Ding, Y., Yan, Y., Chen, D., Ran, L., Mi, J., Lu, L., et al. (2019). Modulating effects of polysaccharides from the fruits of Lycium barbarum on the immune response and gut microbiota in cyclophosphamide-treated mice. Food Funct. 10, 3671–3683. doi: 10.1039/C9FO00638A

PubMed Abstract | CrossRef Full Text | Google Scholar

Gong, G., Liu, Q., Deng, Y., Dang, T., Dai, W., Liu, T., et al. (2020). Arabinogalactan derived from Lycium barbarum fruit inhibits cancer cell growth via cell cycle arrest and apoptosis. Int. J. Biol. Macromol. 149, 639–650. doi: 10.1016/j.ijbiomac.2020.01.251

PubMed Abstract | CrossRef Full Text | Google Scholar

Hekimi, S., Lapointe, J., and Wen, Y. (2011). Taking a “good” look at free radicals in the aging process. Trends Cell Biol. 21, 569–576. doi: 10.1016/j.tcb.2011.06.008

PubMed Abstract | CrossRef Full Text | Google Scholar

Huang, C., Xiong, C., and Kornfeld, K. (2004). Measurements of age-related changes of physiological processes that predict lifespan of Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 101, 8084–8089. doi: 10.1073/pnas.0400848101

PubMed Abstract | CrossRef Full Text | Google Scholar

Huang, W., Zhao, M., Wang, X., Tian, Y., Wang, C., Sun, J., et al. (2022). Revisiting the structure of arabinogalactan from Lycium barbarum and the impact of its side chain on anti-ageing activity. Carbohydr. Polym. 286, 119282. doi: 10.1016/j.carbpol.2022.119282

PubMed Abstract | CrossRef Full Text | Google Scholar

Huang, X., Wang, C., Chen, L., Zhang, T., Leung, K. L., and Wong, G. (2021). Human amyloid beta and α-synuclein co-expression in neurons impair behavior and recapitulate features for Lewy body dementia in Caenorhabditis elegans. Biochim. Biophys. Acta Mol. Basis Dis. 1867:166203. doi: 10.1016/j.bbadis.2021.166203

PubMed Abstract | CrossRef Full Text | Google Scholar

Huang, Y., Zheng, Y., Yang, F., Feng, Y., Xu, K., Wu, J., et al. (2022). Lycium barbarum Glycopeptide prevents the development and progression of acute colitis by regulating the composition and diversity of the gut microbiota in mice. Front. Cell. Infect. Microbiol. 12:921075. doi: 10.3389/fcimb.2022.921075

PubMed Abstract | CrossRef Full Text | Google Scholar

Jia, W., Wang, C., Zheng, J., Li, Y., Yang, C., Wan, Q.-L., et al. (2022). Pioglitazone hydrochloride extends the lifespan of Caenorhabditis elegans by activating DAF-16/FOXO- and SKN-1/NRF2-Related signaling pathways. Oxid. Med. Cell. Longev. 2022:8496063. doi: 10.1155/2022/8496063

PubMed Abstract | CrossRef Full Text | Google Scholar

Jin, M., Huang, Q., Zhao, K., and Shang, P. (2013). Biological activities and potential health benefit effects of polysaccharides isolated from Lycium barbarum L. Int. J. Biol. Macromol. 54, 16–23. doi: 10.1016/j.ijbiomac.2012.11.023

PubMed Abstract | CrossRef Full Text | Google Scholar

Li, S.-T., Zhao, H.-Q., Zhang, P., Liang, C.-Y., Zhang, Y.-P., Hsu, A.-L., et al. (2019). DAF-16 stabilizes the aging transcriptome and is activated in mid-aged Caenorhabditis elegans to cope with internal stress. Aging Cell 18:e12896. doi: 10.1111/acel.12896

PubMed Abstract | CrossRef Full Text | Google Scholar

Liang, R., Zhao, Q., Zhu, Q., He, X., Gao, M., and Wang, Y. (2021). Lycium barbarum polysaccharide protects ARPE-19 cells against H2O2-induced oxidative stress via the Nrf2/HO-1 pathway. Mol. Med. Rep. 24:769. doi: 10.3892/mmr.2021.12409

PubMed Abstract | CrossRef Full Text | Google Scholar

Mao, F., Xiao, B., Jiang, Z., Zhao, J., Huang, X., and Guo, J. (2011). Anticancer effect of Lycium barbarum polysaccharides on colon cancer cells involves G0/G1 phase arrest. Med. Oncol. 28, 121–126. doi: 10.1007/s12032-009-9415-5

PubMed Abstract | CrossRef Full Text | Google Scholar

Masci, A., Carradori, S., Casadei, M. A., Paolicelli, P., Petralito, S., Ragno, R., et al. (2018). Lycium barbarum polysaccharides: Extraction, purification, structural characterisation and evidence about hypoglycaemic and hypolipidaemic effects. A review. Food Chem. 254, 377–389. doi: 10.1016/j.foodchem.2018.01.176

PubMed Abstract | CrossRef Full Text | Google Scholar

Meng, J., Lv, Z., Guo, M., Sun, C., Li, X., Jiang, Z., et al. (2022). A Lycium barbarum extract inhibits β-amyloid toxicity by activating the antioxidant system and mtUPR in a Caenorhabditis elegans model of Alzheimer’s disease. FASEB J. 36:e22156. doi: 10.1096/fj.202101116RR

PubMed Abstract | CrossRef Full Text | Google Scholar

Moskalev, A., Guvatova, Z., Lopes, I. A., Beckett, C. W., Kennedy, B. K., De Magalhaes, J. P., et al. (2022). Targeting aging mechanisms: Pharmacological perspectives. Trends Endocrinol. Metab. 33, 266–280. doi: 10.1016/j.tem.2022.01.007

PubMed Abstract | CrossRef Full Text | Google Scholar

Motola, D. L., Cummins, C. L., Rottiers, V., Sharma, K. K., Li, T., Li, Y., et al. (2006). Identification of ligands for DAF-12 that govern dauer formation and reproduction in C. elegans. Cell 124, 1209–1223. doi: 10.1016/j.cell.2006.01.037

PubMed Abstract | CrossRef Full Text | Google Scholar

Niccoli, T., and Partridge, L. (2012). Ageing as a risk factor for disease. Curr. Biol. 22, R741–R752. doi: 10.1016/j.cub.2012.07.024

PubMed Abstract | CrossRef Full Text | Google Scholar

Niu, Y., Liao, J., Zhou, H., Wang, C. C., Wang, L., and Fan, Y. (2022). Flavonoids from Lycium barbarum leaves exhibit anti-aging effects through the redox-modulation. Molecules 27:4952. doi: 10.3390/molecules27154952

PubMed Abstract | CrossRef Full Text | Google Scholar

Palikaras, K., Lionaki, E., and Tavernarakis, N. (2015). Coordination of mitophagy and mitochondrial biogenesis during ageing in C. elegans. Nature 521, 525–528. doi: 10.1038/nature14300

PubMed Abstract | CrossRef Full Text | Google Scholar

Park, S.-J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., et al. (2012). Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148, 421–433. doi: 10.1016/j.cell.2012.01.017

PubMed Abstract | CrossRef Full Text | Google Scholar

Peng, X.-M., Huang, L.-J., Qi, C.-H., Zhang, Y.-X., and Tian, G.-Y. (2001). Studies on chemistry and immunomodulating mechanism of a glycoconjugate from Lycium barbarum L. Chin. J. Chem. 19, 1190–1197. doi: 10.1002/cjoc.20010191206

CrossRef Full Text | Google Scholar

Ryu, D., Mouchiroud, L., Andreux, P. A., Katsyuba, E., Moullan, N., Nicolet-Dit-Félix, A. A., et al. (2016). Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat. Med. 22, 879–888. doi: 10.1038/nm.4132

PubMed Abstract | CrossRef Full Text | Google Scholar

Stegemann, S., Ecker, F., Maio, M., Kraahs, P., Wohlfart, R., Breitkreutz, J., et al. (2010). Geriatric drug therapy: Neglecting the inevitable majority. Ageing Res. Rev. 9, 384–398. doi: 10.1016/j.arr.2010.04.005

PubMed Abstract | CrossRef Full Text | Google Scholar

Tang, R., Chen, X., Dang, T., Deng, Y., Zou, Z., Liu, Q., et al. (2019). Lycium barbarum polysaccharides extend the mean lifespan of Drosophila melanogaster. Food Funct. 10, 4231–4241. doi: 10.1039/C8FO01751D

PubMed Abstract | CrossRef Full Text | Google Scholar

Tian, G. (1995). Isolation, Purification and Properties of LbGP and Characterization of Its Glycan-Peptide Bond. Chin. Sci. Abstr. Ser. B 4:38.

Google Scholar

Tullet, J. M., Hertweck, M., An, J. H., Baker, J., Hwang, J. Y., Liu, S., et al. (2008). Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell 132, 1025–1038. doi: 10.1016/j.cell.2008.01.030

PubMed Abstract | CrossRef Full Text | Google Scholar

Wan, Q. L., Meng, X., Dai, W., Luo, Z., Wang, C., Fu, X., et al. (2021). N(6)-methyldeoxyadenine and histone methylation mediate transgenerational survival advantages induced by hormetic heat stress. Sci. Adv. 7:eabc3026. doi: 10.1126/sciadv.abc3026

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, W., Xue, C., and Mao, X. (2020). Radioprotective effects and mechanisms of animal, plant and microbial polysaccharides. Int. J. Biol. Macromol. 153, 373–384. doi: 10.1016/j.ijbiomac.2020.02.203

PubMed Abstract | CrossRef Full Text | Google Scholar

Wei, Y., and Kenyon, C. (2016). Roles for ROS and hydrogen sulfide in the longevity response to germline loss in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 113, E2832–E2841. doi: 10.1073/pnas.1524727113

PubMed Abstract | CrossRef Full Text | Google Scholar

Xiao, Y., Zhang, H., Sheng, Y., Liu, F., Gao, J., Liu, G., et al. (2022). Usnic Acid extends healthspan and improves the neurodegeneration diseases via mTOR/PHA-4 signaling pathway in Caenorhabditis elegans. iScience 25:105539. doi: 10.1016/j.isci.2022.105539

PubMed Abstract | CrossRef Full Text | Google Scholar

Xiong, L., Deng, N., Zheng, B., Li, T., and Liu, R. H. (2021). HSF-1 and SIR-2.1 linked insulin-like signaling is involved in goji berry (Lycium spp.) extracts promoting lifespan extension of Caenorhabditis elegans. Food Funct. 12, 7851–7866. doi: 10.1039/D0FO03300F

PubMed Abstract | CrossRef Full Text | Google Scholar

Zeng, W., Wu, A. G., Zhou, X.-G., Khan, I., Zhang, R. L., Lo, H. H., et al. (2021). Saponins isolated from Radix polygalae extent lifespan by modulating complement C3 and gut microbiota. Pharmacol. Res. 170:105697. doi: 10.1016/j.phrs.2021.105697

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, F., Zhang, X., Guo, S., Cao, F., Zhang, X., Wang, Y., et al. (2020). An acidic heteropolysaccharide from Lycii fructus: Purification, characterization, neurotrophic and neuroprotective activities in vitro. Carbohydr. Polym. 249:116894. doi: 10.1016/j.carbpol.2020.116894

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, F., Zhang, X., Liang, X., Wu, K., Cao, Y., Ma, T., et al. (2022). Defensing against oxidative stress in Caenorhabditis elegans of a polysaccharide LFP-05S from Lycii fructus. Carbohydr. Polym. 289:119433. doi: 10.1016/j.carbpol.2022.119433

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, L., Li, Q., Zheng, G., Chen, Y., Huang, M., Zhang, L., et al. (2017). Protective effect of Lycium barbarum polysaccharides against cadmium-induced testicular toxicity in male mice. Food Funct 8, 2322–2330. doi: 10.1039/c6fo01583b

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, Z., Zhou, Y., Fan, H., Billy, K. J., Zhao, Y., Zhan, X., et al. (2019). Effects of Lycium barbarum polysaccharides on health and aging of C. elegans depend on daf-12/daf-16. Oxid. Med. Cell. Longev. 2019:6379493. doi: 10.1155/2019/6379493

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhou, X., Zhang, Z., Shi, H., Liu, Q., Chang, Y., Feng, W., et al. (2022). Effects of Lycium barbarum glycopeptide on renal and testicular injury induced by di(2-ethylhexyl) phthalate. Cell Stress Chaperones 27, 257–271. doi: 10.1007/s12192-022-01266-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: Lycium barbarum glycopeptide, Caenorhabditis elegans, antiaging, Parkinson’s disease, health span

Citation: Zheng J, Luo Z, Chiu K, Li Y, Yang J, Zhou Q, So K-F and Wan Q-L (2023) Lycium barbarum glycopetide prolong lifespan and alleviate Parkinson’s disease in Caenorhabditis elegans. Front. Aging Neurosci. 15:1156265. doi: 10.3389/fnagi.2023.1156265

Received: 01 February 2023; Accepted: 20 June 2023;
Published: 04 July 2023.

Edited by:

Huaibin Cai, National Institute on Aging (NIH), United States

Reviewed by:

Zhiquan Li, University of Copenhagen, Denmark
Xiao-Gang Zhou, Southwest Medical University, China

Copyright © 2023 Zheng, Luo, Chiu, Li, Yang, Zhou, So and Wan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Qin-Li Wan, wanqinli@hotmail.com; Kwok-Fai So, hrmaskf@hku.hk

These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.